Danielle Brandman, MD, MAS

Title(s)Associate Professor, Medicine
SchoolSchool of Medicine
Address513 Parnassus Avenue, MSB
San Francisco CA 94117
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San Francisco Residency 2008Internal Medicine
    University of California, San FranciscoFellowship2011Gastroenterology
    University of California, San FranciscoM.A.S. in Clinical Research2011Advanced Training in Clinical Research
    University of California, San FranciscoFellowship2012Transplant Hepatology
    University of California, San Francisco02/2020Diversity, Equity, and Inclusion Champion Training
    Collapse Awards and Honors
    UCSF2015Haile T. Debas Academy of Medical Educators, Excellence in Teaching Award
    CTSI Resident Research Program2016Resident Mentor of the Year

    Collapse ORNG Applications 
    Collapse Academic Senate

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Letter: non-invasive prediction models to exclude cirrhosis in NAFLD-not everyone fits the mould. Authors' reply. Aliment Pharmacol Ther. 2022 Jul; 56(1):182-183. Brandman D, Boyle M, McPherson S, Van Natta ML, Sanyal AJ, Kowdley K, Neuschwander-Tetri B, Chalasani N, Abdelmalek MF, Terrault NA, McCullough A, Bettencourt R, Caussy C, Kleiner DE, Behling C, Tonascia J, Anstee QM, Loomba R. PMID: 35689309.
      View in: PubMed   Mentions:
    2. Comparison of clinical prediction rules for ruling out cirrhosis in nonalcoholic fatty liver disease (NAFLD). Aliment Pharmacol Ther. 2022 Jun; 55(11):1441-1451. Brandman D, Boyle M, McPherson S, Van Natta ML, Sanyal AJ, Kowdley K, Neuschwander-Tetri B, Chalasani N, Abdelmalek MF, Terrault NA, McCullough A, Bettencourt R, Caussy C, Kleiner DE, Behling C, Tonascia J, Anstee QM, Loomba R, Members of the Nonalcoholic Steatohepatitis Clinical Research Network. PMID: 35302256; PMCID: PMC9098681.
      View in: PubMed   Mentions:
    3. Factors Impacting Survival in Those Transplanted for NASH Cirrhosis: Data From the NailNASH Consortium. Clin Gastroenterol Hepatol. 2022 Feb 18. Rinella ME, Satapathy SK, Brandman D, Smith C, Elwir S, Xia J, Gibson M, Figueredo C, Angirekula M, Vanatta JM, Sarwar R, Jiang Y, Gregory D, Agostini T, Ko J, Podila P, Gallo G, Watt KD, Siddiqui MS. PMID: 35189388.
      View in: PubMed   Mentions:
    4. Nonviral liver disease is the leading indication for liver transplant in the United States in persons living with human immunodeficiency virus. Am J Transplant. 2021 09; 21(9):3148-3156. Campos-Varela I, Dodge JL, Terrault NA, Brandman D, Price JC. PMID: 33749113; PMCID: PMC8522205.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    5. Jaundice in Polycystic Liver Disease: More Than Meets the Eye. Clin Liver Dis (Hoboken). 2021 Mar; 17(3):165-168. Brandman D. PMID: 33868659; PMCID: PMC8043709.
      View in: PubMed   Mentions:
    6. The Updated US Preventive Services Task Force Hepatitis B Screening Recommendations-Staying Committed. JAMA Intern Med. 2021 03 01; 181(3):310-312. Xu CQ, Zhou K, Brandman D. PMID: 33320176.
      View in: PubMed   Mentions:    Fields:    
    7. Disseminated Legionella micdadei infection in a liver transplant patient presenting as pulmonary nodules and a laryngeal lesion. Transpl Infect Dis. 2021 Jun; 23(3):e13563. Bond AR, Bainbridge E, Doernberg SB, Babik JM, Miller S, Khanafshar E, Henry T, David A, Russell M, Brandman D, Sherman CB, Yao F, Fung M. PMID: 33434394.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    8. Obesity Management of Liver Transplant Waitlist Candidates and Recipients. Clin Liver Dis. 2021 02; 25(1):1-18. Brandman D. PMID: 33978572.
      View in: PubMed   Mentions:    Fields:    
    9. Updated Hepatitis C Virus Screening Recommendation-A Step Forward. JAMA Intern Med. 2020 05 01; 180(5):637-639. Price JC, Brandman D. PMID: 32119030.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    10. Who Should Treat Fatty Liver Disease: Primary Care or Hepatology? Clin Liver Dis (Hoboken). 2019 Jun; 13(6):158-161. Brandman D. PMID: 31316762; PMCID: PMC6605735.
      View in: PubMed   Mentions:
    11. Treatment of Fatty Liver Disease-Time to Implement Common Sense Measures. JAMA Intern Med. 2019 Jul 01. Adler E, Brandman D. PMID: 31260055.
      View in: PubMed   Mentions: 1     Fields:    
    12. Evaluating Prognostic Factors for Liver Transplantation Among United States Patients With Hereditary Transthyretin-Mediated (hATTR) Amyloidosis Using National Registry Data. Prog Transplant. 2019 09; 29(3):213-219. Brandman D, Lin H, McManus A, Agarwal S, Gache LM, Irish W, Gollob J, Živkovic SA. PMID: 31167608.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Alcohol use in patients with non-alcoholic fatty liver: a tangled web of causality. Hepatobiliary Surg Nutr. 2019 Jun; 8(3):277-279. Brandman D, Terrault NA. PMID: 31245413; PMCID: PMC6561883.
      View in: PubMed   Mentions:
    14. Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage. Clin Gastroenterol Hepatol. 2019 08; 17(9):1877-1885.e5. Siddiqui MS, Yamada G, Vuppalanchi R, Van Natta M, Loomba R, Guy C, Brandman D, Tonascia J, Chalasani N, Neuschwander-Tetri B, Sanyal AJ, NASH Clinical Research Network. PMID: 30616027; PMCID: PMC6609497.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    15. Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2019 01; 17(1):156-163.e2. Siddiqui MS, Vuppalanchi R, Van Natta ML, Hallinan E, Kowdley KV, Abdelmalek M, Neuschwander-Tetri BA, Loomba R, Dasarathy S, Brandman D, Doo E, Tonascia JA, Kleiner DE, Chalasani N, Sanyal AJ, NASH Clinical Research Network. PMID: 29705261; PMCID: PMC6203668.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    16. New presentation of autoimmune hepatitis with erythema multiforme. Hepatology. 2018 04; 67(4):1628-1630. Kushner T, Shinkai K, Fox L, Ying D, Gross A, Balitzer D, Gill R, Brandman D. PMID: 29059460.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease. Hepatology. 2018 01; 67(1):134-144. Vuppalanchi R, Siddiqui MS, Van Natta ML, Hallinan E, Brandman D, Kowdley K, Neuschwander-Tetri BA, Loomba R, Dasarathy S, Abdelmalek M, Doo E, Tonascia JA, Kleiner DE, Sanyal AJ, Chalasani N, NASH Clinical Research Network. PMID: 28859228; PMCID: PMC5739967.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    18. Weighing the risks: Morbid obesity and diabetes are associated with increased risk of death on the liver transplant waiting list. Liver Int. 2018 03; 38(3):553-563. Kardashian AA, Dodge JL, Roberts J, Brandman D. PMID: 28727287.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    19. Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma. Liver Transpl. 2017 08; 23(8):1015-1022. Lewin SM, Mehta N, Kelley RK, Roberts JP, Yao FY, Brandman D. PMID: 28340509.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    20. Optimization of the mean arterial pressure and timing of surgical decompression in traumatic spinal cord injury: a retrospective study. Spinal Cord. 2017 Nov; 55(11):1033-1038. Dakson A, Brandman D, Thibault-Halman G, Christie SD. PMID: 28631747.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    21. Editorial: are earlier referrals to transplant centres responsible for improved outcomes in patients with acute liver failure? Aliment Pharmacol Ther. 2017 05; 45(9):1272-1273. Brandman D. PMID: 28370044.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. PS-124 Comparison of clinical prediction rules for detection of cirrhosis in non-alcoholic fatty liver disease: a multicenter, international, collaborative study- NASH CRN (USA) and Newcastle (UK) Cohort. Journal of Hepatology. 2017 Jan 1; 66(1):s69-s70. Brandman BD, Boyle BM, McPherson MS, Van Natta VM, Sanyal SA, Kowdley KK, Tetri TB, Chalassani CN, Abdelmalek AM, Terrault TN, McCullough MA, Bettencourt BR, Caussy CC, Kleiner KD, Behling BC, Doo DE, Tonascia TJ, Anstee AQ, Loomba LR. .
      View in: Publisher Site   Mentions:
    23. Early Post-Operative Outcomes in Liver Transplantation for Nonalcoholic Steatohepatitis: A Retrospective Analysis. Transplantation Journal. 2014 Jul 1; 98:740. Zeng ZL, Brandman BD, Roberts RJ, Terrault TN. .
      View in: Publisher Site   Mentions:
    24. Body Mass Index (BMI) and Survival After Liver Transplantation LT): Influence of the Extremes of BMI. Transplantation Journal. 2014 Jul 1; 98:740. Epstein ES, Brandman BD, Dodge DJ, Roberts RJ, Terrault TN. .
      View in: Publisher Site   Mentions:
    25. Impact of insulin resistance on HCV treatment response and impact of HCV treatment on insulin sensitivity using direct measurements of insulin action. Diabetes Care. 2012 May; 35(5):1090-4. Brandman D, Bacchetti P, Ayala CE, Maher JJ, Khalili M. PMID: 22399695; PMCID: PMC3329815.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsCTClinical Trials
    26. Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus. Liver Transpl. 2011 Dec; 17(12):1380-6. Brandman D, Pingitore A, Lai JC, Roberts JP, Ferrell L, Bass NM, Terrault NA. PMID: 21770018; PMCID: PMC3712627.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    27. Pretransplant severe hepatic encephalopathy, peritransplant sodium and post-liver transplantation morbidity and mortality. Liver Int. 2012 Jan; 32(1):158-64. Brandman D, Biggins SW, Hameed B, Roberts JP, Terrault NA. PMID: 22098119.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    28. Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder. Psychiatry Res. 2002 Aug 05; 111(1):11-20. Canuso CM, Goldstein JM, Wojcik J, Dawson R, Brandman D, Klibanski A, Schildkraut JJ, Green AI. PMID: 12140115.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    Danielle's Networks
    Concepts (125)
    Derived automatically from this person's publications.
    Co-Authors (31)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department